SCHEMBL20218295

SCHEMBL20218295

C=C1N[C@@H](CNCC)C[C@@H]1OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19597065 1.00 — —
SCHEMBL23557741 0.65 MTNR1A (0.33) —
SCHEMBL10238587 0.60 — —
SCHEMBL25994335 0.58 SAT1 (0.38) —
SCHEMBL24129485 0.58 SAT1 (0.38) —
SCHEMBL14269728 0.57 CD274 (0.43) —
SCHEMBL21290617 0.57 CD274 (0.43) —
SCHEMBL21673405 0.57 CD274 (0.43) —
SCHEMBL18579219 0.57 — —
SCHEMBL24660009 0.56 CD274 (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3330272-A1 FUSED TRICYCLIC HETEROCYCLIC COMPOUNDS AS HIV INTEGRASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2018-06-06 — — EP disclosed
Send feedback